Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Compass Therapeutics ... In a report issued on April 17, Argus Research also downgraded the ...

Compass Therapeutics has an analyst consensus ... a 32.4% upside from current levels. In a report issued on April 17, Argus Research also downgraded the stock to Hold.

Gov. Sarah Sanders on Wednesday (April 16) announced two vetoes — a bill veto and a line-item veto — her first two vetoes of the 95th General Assembly. Her first announced veto was HB 1889, which was ...